Testing effectiveness (Phase 2)Study completedNCT01447914
What this trial is testing
Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma
Who this might be right for
Refractory Multiple Myeloma
National Cancer Institute (NCI) 16